vs

Side-by-side financial comparison of MOTORCAR PARTS OF AMERICA INC (MPAA) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

MOTORCAR PARTS OF AMERICA INC is the larger business by last-quarter revenue ($167.7M vs $142.0M, roughly 1.2× Oncology Institute, Inc.). MOTORCAR PARTS OF AMERICA INC runs the higher net margin — 1.1% vs -5.3%, a 6.3% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs -9.9%). Oncology Institute, Inc. produced more free cash flow last quarter ($2.2M vs $-8.6M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs -5.9%).

Toyota Motor North America (TMNA) is the operating subsidiary that oversees all operations of the Toyota Motor Corporation in Canada, Mexico, and the United States. Its operations include research and development, manufacturing, sales, marketing, after sales and corporate functions, which are controlled by TMNA but sometimes executed by other subsidiaries and holding companies. The company is headquartered in Plano, Texas, with offices in several locations including Georgetown, Kentucky, Ann ...

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

MPAA vs TOI — Head-to-Head

Bigger by revenue
MPAA
MPAA
1.2× larger
MPAA
$167.7M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+51.5% gap
TOI
41.6%
-9.9%
MPAA
Higher net margin
MPAA
MPAA
6.3% more per $
MPAA
1.1%
-5.3%
TOI
More free cash flow
TOI
TOI
$10.8M more FCF
TOI
$2.2M
$-8.6M
MPAA
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
-5.9%
MPAA

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
MPAA
MPAA
TOI
TOI
Revenue
$167.7M
$142.0M
Net Profit
$1.8M
$-7.5M
Gross Margin
19.6%
Operating Margin
5.0%
-4.9%
Net Margin
1.1%
-5.3%
Revenue YoY
-9.9%
41.6%
Net Profit YoY
-22.4%
43.0%
EPS (diluted)
$0.09
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MPAA
MPAA
TOI
TOI
Q4 25
$167.7M
$142.0M
Q3 25
$221.5M
$136.6M
Q2 25
$188.4M
$119.8M
Q1 25
$193.1M
$104.4M
Q4 24
$186.2M
$100.3M
Q3 24
$208.2M
$99.9M
Q2 24
$169.9M
$98.6M
Q1 24
$189.5M
$94.7M
Net Profit
MPAA
MPAA
TOI
TOI
Q4 25
$1.8M
$-7.5M
Q3 25
$-2.1M
$-16.5M
Q2 25
$3.0M
$-17.0M
Q1 25
$-722.0K
$-19.6M
Q4 24
$2.3M
$-13.2M
Q3 24
$-3.0M
$-16.1M
Q2 24
$-18.1M
$-15.5M
Q1 24
$1.3M
$-19.9M
Gross Margin
MPAA
MPAA
TOI
TOI
Q4 25
19.6%
Q3 25
19.3%
Q2 25
18.0%
Q1 25
19.9%
Q4 24
24.1%
Q3 24
19.8%
Q2 24
17.2%
Q1 24
18.4%
Operating Margin
MPAA
MPAA
TOI
TOI
Q4 25
5.0%
-4.9%
Q3 25
7.4%
-5.9%
Q2 25
10.7%
-9.4%
Q1 25
8.4%
-9.5%
Q4 24
9.4%
-11.9%
Q3 24
6.0%
-13.9%
Q2 24
-3.8%
-16.6%
Q1 24
6.4%
-19.0%
Net Margin
MPAA
MPAA
TOI
TOI
Q4 25
1.1%
-5.3%
Q3 25
-1.0%
-12.1%
Q2 25
1.6%
-14.2%
Q1 25
-0.4%
-18.8%
Q4 24
1.2%
-13.1%
Q3 24
-1.4%
-16.1%
Q2 24
-10.6%
-15.7%
Q1 24
0.7%
-21.0%
EPS (diluted)
MPAA
MPAA
TOI
TOI
Q4 25
$0.09
$-0.04
Q3 25
$-0.11
$-0.14
Q2 25
$0.15
$-0.15
Q1 25
$-0.03
$-0.21
Q4 24
$0.11
$-0.14
Q3 24
$-0.15
$-0.18
Q2 24
$-0.92
$-0.17
Q1 24
$0.06
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MPAA
MPAA
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$19.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$258.5M
$-15.7M
Total Assets
$991.3M
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MPAA
MPAA
TOI
TOI
Q4 25
$19.6M
Q3 25
$17.7M
Q2 25
$14.5M
Q1 25
$11.3M
Q4 24
$12.7M
Q3 24
$12.3M
Q2 24
$9.4M
$9.9M
Q1 24
$15.8M
$29.8M
Stockholders' Equity
MPAA
MPAA
TOI
TOI
Q4 25
$258.5M
$-15.7M
Q3 25
$258.5M
$-12.3M
Q2 25
$260.1M
$-9.0M
Q1 25
$257.7M
$5.1M
Q4 24
$262.7M
$3.6M
Q3 24
$264.0M
$15.5M
Q2 24
$267.2M
$29.2M
Q1 24
$285.1M
$41.3M
Total Assets
MPAA
MPAA
TOI
TOI
Q4 25
$991.3M
$164.7M
Q3 25
$990.0M
$163.6M
Q2 25
$973.4M
$159.8M
Q1 25
$957.6M
$164.0M
Q4 24
$949.5M
$172.7M
Q3 24
$986.2M
$179.2M
Q2 24
$978.0M
$179.6M
Q1 24
$1.0B
$204.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MPAA
MPAA
TOI
TOI
Operating Cash FlowLast quarter
$-8.2M
$3.2M
Free Cash FlowOCF − Capex
$-8.6M
$2.2M
FCF MarginFCF / Revenue
-5.2%
1.5%
Capex IntensityCapex / Revenue
0.2%
0.7%
Cash ConversionOCF / Net Profit
-4.63×
TTM Free Cash FlowTrailing 4 quarters
$27.7M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MPAA
MPAA
TOI
TOI
Q4 25
$-8.2M
$3.2M
Q3 25
$21.9M
$-12.6M
Q2 25
$10.0M
$-10.2M
Q1 25
$9.1M
$-5.0M
Q4 24
$34.4M
$4.2M
Q3 24
$22.9M
$819.0K
Q2 24
$-20.8M
$-15.7M
Q1 24
$-9.3M
$-15.9M
Free Cash Flow
MPAA
MPAA
TOI
TOI
Q4 25
$-8.6M
$2.2M
Q3 25
$20.8M
$-13.2M
Q2 25
$9.2M
$-11.4M
Q1 25
$6.2M
$-5.3M
Q4 24
$33.7M
$2.4M
Q3 24
$22.3M
$417.0K
Q2 24
$-21.3M
$-17.5M
Q1 24
$-9.8M
$-16.5M
FCF Margin
MPAA
MPAA
TOI
TOI
Q4 25
-5.2%
1.5%
Q3 25
9.4%
-9.7%
Q2 25
4.9%
-9.5%
Q1 25
3.2%
-5.1%
Q4 24
18.1%
2.4%
Q3 24
10.7%
0.4%
Q2 24
-12.6%
-17.7%
Q1 24
-5.2%
-17.4%
Capex Intensity
MPAA
MPAA
TOI
TOI
Q4 25
0.2%
0.7%
Q3 25
0.5%
0.4%
Q2 25
0.4%
1.0%
Q1 25
1.5%
0.3%
Q4 24
0.4%
1.8%
Q3 24
0.3%
0.4%
Q2 24
0.3%
1.9%
Q1 24
0.3%
0.6%
Cash Conversion
MPAA
MPAA
TOI
TOI
Q4 25
-4.63×
Q3 25
Q2 25
3.30×
Q1 25
Q4 24
15.00×
Q3 24
Q2 24
Q1 24
-6.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MPAA
MPAA

Reportable Segment Aggregation Before Other Operating Segment$156.3M93%
Other$11.4M7%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons